American Society of Clinical Oncology

SHERPA: White

People

  1. Sabbatini
    Sabbatini
  2. Aghajanian
    Aghajanian
  3. Hensley
    Hensley
  4. Tew
    Tew
  5. Konner
    Konner
  6. Iasonos
    Iasonos
  7. O'Cearbhaill
    O'Cearbhaill
  8. Grisham
    Grisham
  9. Makker
    Makker
  10. Zhou
    Zhou

Groups

  1. Department of Medicine (73)
  2. GDMT, Medicine (73)
  3. Gynecologic Medicine Service (73)
  4. Gynecology Disease Management Team (73)
  5. Solid Tumor Oncology Division (73)
  6. Epidemiology and Biostatistics (22)
  7. Biostatistics Service (18)
  8. Nursing (17)
  9. Hematologic Malignancies, Division of (16)
  10. Surgery (13)
Search Within
  1. "Paul Sabbatini"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (20)
Groups
  1. Department of Medicine (73)
  2. GDMT, Medicine (73)
  3. Gynecologic Medicine Service (73)
  4. Gynecology Disease Management Team (73)
  5. Solid Tumor Oncology Division (73)
  6. Epidemiology and Biostatistics (22)

More Groups

People
  1. Paul Sabbatini (73)
  2. Carol Aghajanian (39)
  3. Martee Hensley (30)
  4. David Spriggs (26)
  5. William Tew (19)
  6. Jason Konner (18)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (2)
  5. 2018 (3)
  6. 2017 (6)

More Years

Publications
  1. Journal of Clinical Oncology (71)
  2. JCO Clinical Cancer Informatics (1)
  3. JCO Precision Oncology (1)

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Early clinical progression in patients with gynecologic malignancies receiving immunomodulatory antibody therapy
    Meeting Abstract

    Zamarin, D.; Martin, M.; Zecca, N.; Iasonos, A.; Zhou, Q.; Aghajanian, C.; Sabbatini, P.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    Meeting Abstract

    Basch, E. M.; Deal, A. M.; Dueck, A. C.; Bennett, A. V.; Atkinson, T. M.; Scher, H. I.; Kris, M. G.; Hudis, C. A.; Sabbatini, P.; Dulko, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II randomized, double-blind trial of a polyvalent vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian (EOC), fallopian tube, or peritoneal cancer who are in second or third complete remission
    Meeting Abstract

    Sabbatini, P.; Chen, L. M.; Lucci, J. A.; Behbakht, K.; Spirtos, N. M.; Muller, C.; Benigno, B. B.; Powell, M. A.; Berry, E.; Tewari, K. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC)
    Meeting Abstract

    O'Cearbhaill, R. E.; McMeekin, D. S.; Mantia-Smaldone, G.; Gunderson, C.; Sabbatini, P.; Cattaruzza, F.; Fischer, M.; Kapoun, A. M.; Xu, L.; Dupont, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Bevacizumab after bevacizumab in platinum-sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213
    Meeting Abstract

    Coleman, R. L.; Brady, M. F.; Herzog, T. J.; Armstrong, D. K.; Sabbatini, P.; Walker, J. L.; Kim, B.; Fujiwara, K.; Tewari, K. S.; O'Malley, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save